Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold)

NCT05450523 is registered in ClinicalTrials.gov with Qingdao HIGHTOP Biotech Co., Ltd. as lead sponsor.

NCT NCT05450523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05450523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold)
Lead sponsor
Qingdao HIGHTOP Biotech Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
December 28, 2021
Completion date
September 7, 2022
Enrollment
220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peritoneal dialysis-associated peritonitis